Company intelligence / Profile preview

Abeomics

San Diego, California, United Statessanbio.nl ↗

Ownership: Private
Employees: ~51
Development stage: Commercial

Overview

Abeomics provides research reagents (not therapeutics); no clinical trial results as the company is not directly developing drugs for clinical use but rather enabling drug discovery and development for others.

Therapeutic areas: Metabolic DisordersRare DiseasesNeurologyOtherInfectious DiseasesOncology
Modalities: AntibodyRecombinant proteinCell lineSmall molecule
Industry: Non-Drug Biotech

Beyond the preview

Go deeper on Abeomics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Abeomics.

Explore the full profile